Abstract
Radiation exudative pericarditis is a rare (up to 24%) complication of radiation and combination treatment for lymphogranulomatosis and lung cancer. As of now, preference is given to drug management of patients with exudative and adhesive-exudative pericarditis. The experience in treating 27 patients with radiation exudative pericarditis has shown that combined drug treatment with anti-inflammatory drugs from different groups, diuretics, and metabolic and vascular agents results in a reduction or disappearance of fluid in the pericardial cavity in 44% of cases, elimination of the signs of heart failure, improvement in central and systemic hemodynamic parameters, and an increase in the quality of life in patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
